The risk of breast cancer associated with CHIP was predominantly driven by mutations in the gene ATM (OR [95% CI] = 3.97 [2.89–5.36], P = 2.02e-18), and DNMT3A (OR [95% CI] = 1.33 [1.03–1.66], P = 0.014). Here, ATM is linked to breast carcinoma.